Literature DB >> 821943

25-Hydroxyvitamin D transport in human plasma. Isolation and partial characterization of calcifidiol-binding protein.

J G Haddad, J Walgate.   

Abstract

The binding protein for 25-hydroxycholecalciferol (25-OH-D3 or calcifidiol) in human plasma has been purified from Cohn Fraction IV. Following in vitro labeling with 25-OH-[3H]D3, the isolation sequence of procedures included: DEAE-cellulose chromatography; gel filtration on Sephadex G-200; chromatography on DEAE-Sephadex; preparative polyacrylamide gel electrophoresis. These procedures resulted in a calcifidiol-binding protein (Cal-BP) which had been purified approximately 170-fold, and which was homogeneous by physical and immunological criteria. The purified Cal-BP had inter-alpha mobility, a sedimentation constant (S20, w) of 3.46 S, and a molecular weight of approximately 59,000. Sucrose gradient ultracentrifugation of Cal-BP and ligand incubations indicated that there was apparently one binding site for either cholecalciferol, calcifidiol or 1,25-dihydroxycholecalciferol per molecule of human Cal-BP. The protein had highest affinity for calcifidiol, displaying an apparent dissociation constant (Kd) of 6.4 X 10(-8) M for this sterol. Specific anti-human Cal-BP antisera were prepared in rabbits, and produced precipitate lines of identity between Cal-BP and human serum. Specific binding of vitamin D3,25-OH-D3, and 1,25-(OH)2D3 by human serum was completely neutralized after immunoprecipitation of the serum with the gamma globulin fraction of anti-Cal-BP antiserum, indicating a common transport protein for these sterols in human plasma. There was no immunological cross-reactivity between Cal-BP and rat or chicken sera, indicating that the Cal-BP in these three sera are immunologically completely distinct. Purified human Cal-BP and human sera also produced lines of identity with commercial anti-human group-specific component (Gc) antisera in radial immunodiffusion experiments. This finding supports an earlier report of the identity of calciferol/calcifidiol-binding protein and group-specific component in human serum. The Cal-BP content of human serum is approximately 10(-5) M, whereas the calcifidiol content is approximately 10(-7) M. Normally, the dominant moiety of human plasma Cal-BP is the apoprotein.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 821943

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Uptake and degradation of filamentous actin and vitamin D-binding protein in the rat.

Authors:  S Dueland; M S Nenseter; C A Drevon
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

2.  Variation in oral calcitriol response in patients with stages 3-4 CKD.

Authors:  Abigail B Shoben; Gregory Levin; Ian H de Boer; Catherine Yeung; Suzanne Watnick; Ernie Ayers; Bryan Kestenbaum
Journal:  Am J Kidney Dis       Date:  2012-01-29       Impact factor: 8.860

3.  Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein.

Authors:  F F Safadi; P Thornton; H Magiera; B W Hollis; M Gentile; J G Haddad; S A Liebhaber; N E Cooke
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

4.  The effect of intramuscularly administered vitamin D3 on serum vitamin D metabolites and electrolytes in vitamin D3 deficient dairy cows.

Authors:  M Sturén
Journal:  Acta Vet Scand       Date:  1985       Impact factor: 1.695

5.  Uptake and degradation of vitamin D binding protein and vitamin D binding protein-actin complex in vivo in the rat.

Authors:  S Dueland; R Blomhoff; J I Pedersen
Journal:  Biochem J       Date:  1990-05-01       Impact factor: 3.857

6.  [Vitamin D-binding protein in human plasma. Analysis of genetic variation].

Authors:  H Cleve
Journal:  Naturwissenschaften       Date:  1985-10

7.  The group-specific protein marker: a possible indicator of syphilis, not human immunodeficiency virus infection.

Authors:  D R Pollard; P Gill; A Day
Journal:  CMAJ       Date:  1988-06-01       Impact factor: 8.262

8.  Molecular analysis of the gene for the human vitamin-D-binding protein (group-specific component): allelic differences of the common genetic GC types.

Authors:  A Braun; R Bichlmaier; H Cleve
Journal:  Hum Genet       Date:  1992-06       Impact factor: 4.132

9.  Extraction of vitamin D metabolites by bones of normal adult dogs.

Authors:  K Olgaard; J Schwartz; D Finco; M Arbelaez; J Haddad; L Avioli; S Klahr; E Slatopolsky
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

10.  A monoclonal antibody against human vitamin-D-binding protein for the analysis of genetic variation in the group-specific component system (Gc).

Authors:  R Hoffmann; A Braun; H Cleve
Journal:  Hum Genet       Date:  1990-01       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.